Market Overview:
The global bioresorbable medical polymer market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for drug delivery and orthopedics applications, and the rising awareness about bioresorbable medical polymers among consumers. Based on type, the global bioresorbable medical polymer market is segmented into polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, and polycaprolactone (PCL). Of these, PLA is expected to account for the largest share of the market in 2018. This can be attributed to its properties such as high tensile strength and low weight ratio that make it suitable for use in various applications such as drug delivery and orthopedics. Based on application, the global bioresorbable medical polymer market is segmented into drug delivery, orthopedics, tissue engineering & regenerative medicine (TERM), cardiovascular implants & stents, others. Orthopedics is expected to account for the largest share of this market in 2018 owing to factors such as rising incidence of bone fractures and growing demand for minimally invasive surgeries.
Product Definition:
A bioresorbable medical polymer is a synthetic or natural material that can be used in medical implants and devices. The polymer is designed to degrade and dissolve over time, eliminating the need for surgical removal. This type of material can be used in a variety of applications, including sutures, stents, and bone screws.
Polylactic Acid (PLA):
Polylactic Acid (PLA) is a biodegradable polymer, produced from renewable resources such as corn starch, tapioca roots and sugarcane. It has the ability to form hydrogels at room temperature when mixed with water or another polymers. PLA possesses several physical properties such as high tensile strength & modulus and good elasticity which makes it suitable for manufacturing of medical devices & implants that require flexibility, toughness and chemical resistance along with low weight.
Polyglycolic Acid (PGA):
Polyglycolic acid (PGA) is a biocompatible thermosetting polymer with an extremely high melting point. It has applications in tissue engineering, drug delivery systems, and medical devices. PGA is used as a coating material for the release of bioactive molecules from the surface of implants or drugs into the body.
Application Insights:
Drug delivery dominated the global bioresorbable medical polymer market in terms of revenue share in 2017. The segment is expected to witness significant growth over the forecast period due to increasing product usage for manufacturing bio-based injectable drugs.
The orthopedics application segment is also estimated to witness lucrative growth during the forecast period owing to rising demand for advanced healthcare services and products, coupled with growing awareness about bone diseases and conditions. Bioresorbable polymers are used as grafts & prosthetics after total knee arthroplasty, hip replacement surgery or spinal fusion surgery among others. Growing number of knee & hip replacement surgeries across various regions coupled with high patient satisfaction levels are expected drive product demand over the coming years.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position over the forecast period. The presence of a large number of local players coupled with increasing R&D activities in this region is anticipated to support growth. China, Japan, and India are some of the largest markets for bioresorbable polymers due to factors such as growing healthcare expenditure, aging population along with rising awareness about advanced medical treatments & devices.
North America accounted for a significant share owing to high demand from end-use industries such as orthopedics and others. Growing demand for bioresorbable polymers due to their advantages over other conventional materials is expected favorably impact market growth during the forecast period.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is mainly due to the advantages offered by these surgeries over traditional open surgery, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. Bioresorbable medical polymers are ideally suited for use in minimally invasive procedures as they can be easily molded into the required shape and then dissolved away after the surgery is complete.
- Growing demand for bioresorbable implants: The global market for bioresorbable implants is expected to grow at a CAGR of 9% from 2016 to 2021. This growth can be attributed to the increasing number of patients requiring implant-based treatments and the growing preference among surgeons for bioresorbable implants over traditional metal or plastic implants. Bioresorbable medical polymers are particularly well suited for use in implant applications as they can provide a temporary scaffold that supports tissue growth until it eventually dissolves away completely without leaving any harmful residues behind.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioresorbable Medical Polymer Market Research Report
By Type
Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), PLGA
By Application
Drug Delivery, Orthopedics, Others
By Companies
Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med, KLS Martin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Bioresorbable Medical Polymer Market Report Segments:
The global Bioresorbable Medical Polymer market is segmented on the basis of:
Types
Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), PLGA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Delivery, Orthopedics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Evonik
- Corbion
- DSM
- Mitsui Chemicals
- PCAS
- Poly-Med
- KLS Martin
Highlights of The Bioresorbable Medical Polymer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polylactic Acid (PLA)
- Polyglycolic Acid (PGA)
- Polysaccharides
- Polycaprolactone (PCL)
- PLGA
- By Application:
- Drug Delivery
- Orthopedics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioresorbable Medical Polymer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioresorbable medical polymers are a type of polymer that can be broken down by the body. This means that they can be removed through natural processes, such as digestion or excretion. They are often used in medical devices and implants because they are biocompatible and have a low toxicity profile.
Some of the major players in the bioresorbable medical polymer market are Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med, KLS Martin.
The bioresorbable medical polymer market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioresorbable Medical Polymer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioresorbable Medical Polymer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioresorbable Medical Polymer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioresorbable Medical Polymer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioresorbable Medical Polymer Market Size & Forecast, 2020-2028
4.5.1 Bioresorbable Medical Polymer Market Size and Y-o-Y Growth
4.5.2 Bioresorbable Medical Polymer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polylactic Acid (PLA)
5.2.2 Polyglycolic Acid (PGA)
5.2.3 Polysaccharides
5.2.4 Polycaprolactone (PCL)
5.2.5 PLGA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Drug Delivery
6.2.2 Orthopedics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioresorbable Medical Polymer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioresorbable Medical Polymer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polylactic Acid (PLA)
9.6.2 Polyglycolic Acid (PGA)
9.6.3 Polysaccharides
9.6.4 Polycaprolactone (PCL)
9.6.5 PLGA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Drug Delivery
9.10.2 Orthopedics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polylactic Acid (PLA)
10.6.2 Polyglycolic Acid (PGA)
10.6.3 Polysaccharides
10.6.4 Polycaprolactone (PCL)
10.6.5 PLGA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Drug Delivery
10.10.2 Orthopedics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polylactic Acid (PLA)
11.6.2 Polyglycolic Acid (PGA)
11.6.3 Polysaccharides
11.6.4 Polycaprolactone (PCL)
11.6.5 PLGA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Drug Delivery
11.10.2 Orthopedics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polylactic Acid (PLA)
12.6.2 Polyglycolic Acid (PGA)
12.6.3 Polysaccharides
12.6.4 Polycaprolactone (PCL)
12.6.5 PLGA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Drug Delivery
12.10.2 Orthopedics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polylactic Acid (PLA)
13.6.2 Polyglycolic Acid (PGA)
13.6.3 Polysaccharides
13.6.4 Polycaprolactone (PCL)
13.6.5 PLGA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Drug Delivery
13.10.2 Orthopedics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioresorbable Medical Polymer Market: Competitive Dashboard
14.2 Global Bioresorbable Medical Polymer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Evonik
14.3.2 Corbion
14.3.3 DSM
14.3.4 Mitsui Chemicals
14.3.5 PCAS
14.3.6 Poly-Med
14.3.7 KLS Martin
